abstract |
The present invention relates to purine compounds that are useful as kinase inhibitors. More particularly, the present invention relates to purine compounds, the methods for their preparation, the pharmaceutical compositions containing these compounds and the uses of these compounds in the treatment of proliferative conditions or disorders. These compounds may be useful as medicaments for the treatment of various proliferative conditions or disorders, including tumors and cancers as well as other disorders or conditions related or associated with PI3 and / or TORm kinases. (See formula I). |